Skip to main content
. 2024 Oct 15;21:69. doi: 10.1186/s12979-024-00474-9

Fig. 1.

Fig. 1

QC alleviated renal damage in lupus-like mice. (A) Schematics for the experimental workflow with MRL/lpr lupus mice. (B) MRL/lpr lupus mice weight in the QC and control groups. (C) Urine protein changes in the MRL/lpr lupus mice treated for 15 weeks, both in the QC group and the control group. (D) Renal pathological changes from MRL/lpr lupus mice (200-fold field of view; H&E staining). (E) Immune complex deposition in the kidney of lupus-like mice, IgG shown in green, C3 shown in red, nuclei shown in blue (200-fold field of view). (F) Statistical analysis of mean fluorescence intensity of IgG and C3 in glomeruli. (G) Serum total IgG levels, Serum ANA levels and serum dsDNA levels in lupus-like mice. (Quercetin: n = 5, Control: n = 5),(*P < 0.05, **P < 0.01, ****P < 0.0001)